This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Impetigo herpetiformis (IH)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Impetigo herpetiformis (IH) is a rare dermatosis of pregnancy

  • natural course of IH is commonly resolved in the postpartum period

  • typically presents during the third trimester of pregnancy and resolves during the postpartum period

  • has been called psoriasis of pregnancy - there is a clinical and histological resemblance to psoriasis

  • may recur in future pregnancies
    • matter of debate whether it represents a pustular form of psoriasis or a separate entity related to pregnancy in cases when there is no personal or family history of psoriasis, when the lesions clear during the postpartum period and never rebound, or when they recur in subsequent pregnancies

  • characteristic features are superficial pustules studded on the periphery of erythematous plaques
  • hypocalcaemia may be a precipitating factor

  • associated fetal complications include stillbirths, placental insufficiency and perinatal death

  • systemic corticosteroids are considered the gold standard in the treatment of IH
    • cyclosporine has been used in steroid resistant cases

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.